Abstract Views :169 |
PDF Views:3
Authors
Affiliations
1 Department of Biotechnology, St. Joseph’s College (Autonomous), Tiruchirappalli, Tamil Nadu, IN
2 Department of Botany, St. Joseph’s College (Autonomous), Tiruchirappalli, Tamil Nadu, IN
3 Department of Biochemistry and Biotechnology, Annamalai University, Chidambaram, Tamil Nadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 10, No 5 (2017), Pagination: 1477-1480
Abstract
Pregnant rats were administered by either sodium valproate (VPA) with 250 mg/kg during fetal neural tube development on embryonic day 12, induces neural tube defects and impairment in behaviors related to autistic spectrum disorder in newborns, which make it a useful animal model of autism. Male rat pups were subjected to behavioral testing to assess exploratory activity, peripheral and central movements and motor activity like grooming and rearing on postnatal day 90. We investigated the role of EGCG (2mg/kg) in reversing cardinal behavioral changes induced by VPA exposed rats. Consumption of EGCG has been associated with neuronal protection against the impact of toxicants. EGCG exerts neuronal cytoprotective action possibly due to antioxidant action and neuroprotective effect could be efficacious in the management of autism.
Keywords
Autism, VPA, EGCG, Behavior.
